Patent · US Active

Antibodies

US9353185B2 · kind B2 · utility

0Cited by

3References

37Claims

0Family size

Assignee

Affitech Research AS · NO

Inventors

Anita Kavlie · Oslo, NO
Sergej KIPRIJANOV · Oslo, NO

Key dates

Filing date	May 16, 2014
Grant date	May 31, 2016
Priority date	—
Expiry date	May 16, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides antibodies which bind to CXC chemokine receptor 4 (CXCR4) and which do not induce significant apoptosis of CXCR4 expressing cells. Also provided are inter alia immunoconjugates and compositions comprising such antibodies and methods and uses involving such antibodies, particularly in the medical and diagnostic fields.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.